Sai Pan
Overview
Explore the profile of Sai Pan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
55
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Dong Z, Wang X, Pan S, Weng T, Chen X, Jiang S, et al.
NPJ Digit Med
. 2025 Jan;
8(1):50.
PMID: 39856403
Differentiating between diabetic nephropathy (DN) and non-diabetic renal disease (NDRD) without a kidney biopsy remains a major challenge, often leading to missed opportunities for targeted treatments that could greatly improve...
2.
Pan S, Niu Y, Duan S, Zhao D, Wang Q, Dong Z, et al.
Front Public Health
. 2024 Aug;
12:1403878.
PMID: 39104895
Background: Population aging is a pivotal trend observed globally, and the exposure to heavy metals can exacerbate the aging process and lead to kidney damage. However, the impact of combined...
3.
Li B, Wang Q, Luo Y, Wang S, Pan S, Zhao W, et al.
Cancers (Basel)
. 2024 May;
16(9).
PMID: 38730580
Background: The immune checkpoint blockade remains obscure in osteosarcoma (OS). We aim to explore the clinical significance of soluble immune checkpoint (ICK)-related proteins in OS. Methods: We profiled 14 soluble...
4.
Ma D, Tang J, He G, Pan S
Materials (Basel)
. 2024 Feb;
17(4).
PMID: 38399207
In the present work, the photodegradation of Rhodamine B with different pH values by using BiO microrods under visible-light irradiation was studied in terms of the dye degradation efficiency, active...
5.
Ying Z, Wen C, Tu H, Li W, Pan S, Li Y, et al.
Obesity (Silver Spring)
. 2023 Sep;
31(12):3043-3055.
PMID: 37731225
Objective: The study's objective was to investigate the association of fat mass index (FMI) and fat-free mass index (FFMI) with all-cause mortality and cause-specific mortality in the Chinese population. Methods:...
6.
Fu Y, Jiang L, Pan S, Chen P, Wang X, Dai N, et al.
Comput Methods Programs Biomed
. 2023 Aug;
241:107747.
PMID: 37619430
Background And Objective: As an advanced technique, immunofluorescence (IF) is one of the most widely-used medical image for nephropathy diagnosis, due to its ease of acquisition with low cost. In...
7.
Li W, Wen C, Li W, Ying Z, Pan S, Li Y, et al.
Diabetol Metab Syndr
. 2023 Aug;
15(1):169.
PMID: 37574540
Background: Higher fasting plasma glucose (FPG) levels were associated with an increased risk of all-cause mortality; however, the associations between long-term FPG trajectory groups and mortality were unclear, especially among...
8.
Pan S, Zhao W, Li Y, Ying Z, Luo Y, Wang Q, et al.
Front Immunol
. 2023 May;
14:1189161.
PMID: 37256126
Background: Immune checkpoint inhibition holds promise as a novel treatment for pancreatic ductal adenocarcinoma (PDAC). The clinical significance of soluble immune checkpoint (ICK) related proteins have not yet fully explored...
9.
Li P, Cao X, Liu W, Zhao D, Pan S, Sun X, et al.
JMIR Public Health Surveill
. 2023 Mar;
9:e39568.
PMID: 36917165
Background: Peritoneal dialysis (PD) care in mainland China has been progressing in the past 10 years. Objective: To complement information from the dialysis registry, a large-scale nationwide survey was conducted...
10.
Pan S, Zhao D, Duan S, Chen X
Int Urol Nephrol
. 2023 Feb;
55(7):1747-1756.
PMID: 36797553
Trimethylamine N-oxide (TMAO) is an intestinal uremic toxin molecule mainly excreted by the kidney. Therefore, the plasma TMAO concentration is significantly increased in chronic kidney disease (CKD) patients, and plasma...